References
- Kailas NA, Sifakis S, Koumantakis E. Contraception during perimenopause. Eur J Contracept Reprod Health Care. 2005;10(1):19–25.
- Somboonporn W, Panna S, Temtanakitpaisan T, et al. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis. Menopause. 2011;18(10):1060–1066.
- Chen BA, Eisenberg DL, Schreiber CA, et al. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Am J Obstet Gynecol. 2020;222(4):S888.e1–S888.e6.
- Makuch MY, Osis MJD, de Padua K, et al. Use of hormonal contraceptives to control menstrual bleeding: attitudes and practice of Brazilian gynecologists. Int J Womens Health. 2013;5:795–801.
- Polis CB, Hussain R, Berry A. There might be blood: a scoping review on women’s responses to contraceptive-induced menstrual bleeding changes. Reprod Health. 2018;15(1):114.
- Belsey EM, Machin D, d‘Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World health organization special programme of research, development and research training in human reproduction. Contraception. 1986;34(3):253–260.
- Gupta J, Kai J, Middleton L, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013;368(2):128–137.
- Laporte M, Charles CM, Metelus S, et al. Reasons reported by women for choosing the levonorgestrel intrauterine system as a contraceptive method. Intl J Gynecology & Obste. 2022;158(3):700–704.
- Gemzell-Danielsson K, Cho S, Inki P, et al. Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling –results of an international survey in 10 countries. Contraception. 2012;86(6):631–638.
- Madden T, Cortez S, Kuzemchak M, et al. Accuracy of information about the intrauterine device on the internet. Am J Obstet Gynecol. 2016;214(4):499.e1–e6.